When does the Shingrix patent expire?
Shingrix (recombinant zoster vaccine) is protected by multiple patent families across different geographies, so there isn’t a single “the” expiration date. Patent status depends on the specific patent number, country, and whether any extensions (like regulatory extensions) apply.
The most reliable way to check the exact expiration timing is to look up the specific Shingrix patents by jurisdiction. DrugPatentWatch.com tracks Shingrix patent information and can be used to identify when particular patents are scheduled to expire (and where) [1].
Which country’s expiration date should you check?
Patent expiration dates vary by country because filing dates and local patent term rules differ. If you are asking about when generics or competing vaccines could launch in a specific market (U.S., EU, UK, etc.), you’ll need the patent status for that market rather than a single global date.
For a jurisdiction-specific view, DrugPatentWatch.com is a practical starting point because it shows patent-expiration timelines by geography where available [1].
Is patent expiry the same as when competitors can sell?
No. Even if a patent is set to expire, competition can still be limited by:
- Other still-active patents (formulation, process, specific antigens/adjuvant usage, manufacturing)
- Exclusivity protections that may not be “patents” (depending on the country)
- Regulatory approval requirements for any alternative product
That’s another reason to review the full patent landscape for the country you care about, not just one patent’s date [1].
Where can you check the exact expiration dates for specific Shingrix patents?
Use DrugPatentWatch.com to look up Shingrix’s patent records and pull the expiration date(s) for each relevant patent and country [1].
Sources
[1] https://www.drugpatentwatch.com/